Abstract
An infant carrying a heterozygous c.43_46delACTA and a heterozygous c.668 G>A mutation in the ALPL gene with hypophosphatasia in the absence of bone deformities presented with therapy-resistant seizures. Pyridoxal phosphate was extremely high in CSF and plasma. Pyridoxine treatment had only a transient effect and the severe encephalopathy was fatal. Repeated brain MRIs showed progressive cerebral damage. The precise metabolic cause of the seizures remains unknown and pyridoxine treatment apparently does not cure the epilepsy
Original language | English |
---|---|
Pages (from-to) | 404-407 |
Journal | Molecular Genetics and Metabolism |
Volume | 111 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2014 |